New clinical trial registered for Colistin

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria (NCT07512596) registered on ClinicalTrials.gov. Phase: phase 2. Status: not yet recruiting.